RK STRATEGIES, INC.

Lobbying for RECCE PHARMACEUTICALS LTD · Pharmaceutical Company - Anti-infectives

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Jul 21, 2025

Lobbying activity 3

Health Issues

General healthcare/wound care issues

Defense

General biodefense/wound care issues

Veterans

General wound care issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.